Monopar Therapeutics (MNPR) Retained Earnings: 2016-2019
Historic Retained Earnings for Monopar Therapeutics (MNPR) over the last 4 years, with Dec 2019 value amounting to -$25.9 million.
- Monopar Therapeutics' Retained Earnings fell 21.82% to -$30.1 million in Q3 2020 from the same period last year, while for Sep 2020 it was -$30.1 million, marking a year-over-year decrease of 21.82%. This contributed to the annual value of -$25.9 million for FY2019, which is 19.51% down from last year.
- Per Monopar Therapeutics' latest filing, its Retained Earnings stood at -$25.9 million for FY2019, which was down 19.51% from -$21.7 million recorded in FY2018.
- Over the past 5 years, Monopar Therapeutics' Retained Earnings peaked at -$1.9 million during FY2016, and registered a low of -$25.9 million during FY2019.
- Moreover, its 3-year median value for Retained Earnings was -$21.7 million (2018), whereas its average is -$22.0 million.
- Data for Monopar Therapeutics' Retained Earnings shows a maximum YoY plummeted of 883.91% (in 2017) over the last 5 years.
- Over the past 4 years, Monopar Therapeutics' Retained Earnings (Yearly) stood at -$1.9 million in 2016, then crashed by 883.91% to -$18.4 million in 2017, then declined by 17.52% to -$21.7 million in 2018, then decreased by 19.51% to -$25.9 million in 2019.